D. Chidester

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

G. Trainor, A. Cocuzza, D. Robertson, 2000, Bioorganic & medicinal chemistry.

Use of the Suzuki reaction for the synthesis of aryl-substituted heterocycles as corticotropin-releasing hormone (CRH) antagonists.

A. Cocuzza, L. Fitzgerald, S. Culp, 1999, Bioorganic & medicinal chemistry letters.

Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines.

E. D. De Souza, F. Hobbs, A. Cocuzza, 1999, Journal of medicinal chemistry.

Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain.

L. Bacheler, G. Trainor, A. Cocuzza, 2001, Bioorganic & medicinal chemistry letters.

Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines.

C. Hodge, Y. Wong, F. Hobbs, 1999, Journal of medicinal chemistry.

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.

G. Trainor, F. Hobbs, A. Cocuzza, 1994, Molecular pharmacology.

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.

F. Hobbs, A. Cocuzza, H. Sands, 1995, Molecular pharmacology.

4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

L. Bacheler, C. Weigelt, A. Cocuzza, 2001, Bioorganic & medicinal chemistry letters.